LabGenomics Participates in Korean Dementia Association Autumn Conference... Promotes One-Stop Dementia Treatment Platform
LabGenomics announced on the 5th that it participated in the Korean Dementia Association Autumn Academic Conference together with Imocog and PeopleBio.
The event was held on the 2nd at the Baekbeom Kim Koo Memorial Hall in Seoul. The program included sessions on ▲digital biomarkers for early diagnosis of dementia ▲lectures on early diagnosis and treatment of dementia using artificial intelligence (AI) ▲recommendations for the appropriate use of lecanemab, a new treatment for Alzheimer's disease, providing time dedicated to overcoming dementia.
Imocog and PeopleBio, who attended alongside LabGenomics, promoted an innovative platform that quickly and easily screens early-stage dementia such as subjective cognitive decline (SCD) and mild cognitive impairment (MCI) through positron emission tomography (PET) scans and digital bio technology, and enables antibody treatment. The goal is to provide a one-stop solution from early-stage screening to accurate diagnosis and treatment.
A company representative said, "It is meaningful to present our solution through the conference amid the increasing number of dementia patients and the rising social and economic costs caused by it," adding, "We will strive to meet market expectations by strengthening cooperation with partner companies and presenting new platforms."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Earlier, LabGenomics attended the Korean Dementia Association Special Symposium last month along with Imocog and seven other companies. The eight healthcare specialized companies plan to provide comprehensive dementia diagnosis and treatment solutions including ▲amyloid antibody treatment (Korea Eisai) ▲blood markers and genomic testing (LabGenomics, PeopleBio) ▲PET imaging solutions (Brightonics Imaging) ▲development and supply of PET radiopharmaceuticals for dementia diagnosis (Ducem Bio) ▲brain disease imaging AI solutions (Neurofit) ▲health checkup linkage and follow-up health management (GC Care) ▲online cognitive function testing and digital therapy (Imocog).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
